These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6104558)

  • 21. Metabolite distribution and rate of residue clearance in turkeys fed a diet containing aflatoxin B1.
    Gregory JF; Goldstein SL; Edds GT
    Food Chem Toxicol; 1983 Aug; 21(4):463-7. PubMed ID: 6413313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
    Bennett RA; Essigmann JM; Wogan GN
    Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excretion and metabolism of orally administered aflatoxin B1 by rhesus monkeys.
    Dalezios JI; Hsieh DP; Wogan GN
    Food Cosmet Toxicol; 1973 Aug; 11(4):605-16. PubMed ID: 4202366
    [No Abstract]   [Full Text] [Related]  

  • 24. Clearance and excretion of intratracheally and orally administered aflatoxin B1 in the rat.
    Coulombe RA; Sharma RP
    Food Chem Toxicol; 1985 Sep; 23(9):827-30. PubMed ID: 3930357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Microsomal and photochemical oxidation of aflatoxin B1].
    Sergeev BL; Bogovskiĭ SP; Veĭdebaum TI; Tanner RKh; Shevchuk IN
    Eksp Onkol; 1985; 7(5):27-30. PubMed ID: 3933949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro.
    Swenson DH; Miller EC; Miller JA
    Biochem Biophys Res Commun; 1974 Oct; 60(3):1036-43. PubMed ID: 4429559
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide.
    Degen GH; Neumann HG
    Carcinogenesis; 1981; 2(4):299-306. PubMed ID: 6791853
    [No Abstract]   [Full Text] [Related]  

  • 31. Aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation with isolated hepatocytes from rats and hamsters.
    Ho LL; Jhee EC; Gopalan P; Tsuji K; Lotlikar PD
    IARC Sci Publ; 1991; (105):427-30. PubMed ID: 1906837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aflatoxin B1: correlations of patterns of metabolism and DNA modification with biological effects.
    Croy RG; Essigmann JM; Wogan GN
    Basic Life Sci; 1983; 24():49-62. PubMed ID: 6407467
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic analysis of aflatoxin B1 activation in rat hepatoma cells.
    Corcos L; Rousset JP; Kiefer F; Wiebel FJ; Weiss MC
    Mol Gen Genet; 1990 Jul; 222(2-3):291-6. PubMed ID: 2125692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
    Groopman JD; Donahue PR; Zhu JQ; Chen JS; Wogan GN
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6492-6. PubMed ID: 3931076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fate of aflatoxin B-1 in fermented dairy products.
    Megalla SE; Mohran MA
    Mycopathologia; 1984 Oct; 88(1):27-9. PubMed ID: 6440020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
    Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
    Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
    [No Abstract]   [Full Text] [Related]  

  • 37. The in vivo disposition of aflatoxin B1 in rat liver.
    Ewaskiewicz JI; Devlin TM; Ch'ih JJ
    Biochem Biophys Res Commun; 1991 Sep; 179(2):1095-100. PubMed ID: 1910338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic exposure to aflatoxin B1 and aflatoxin M1 on the in vivo covalent binding of aflatoxin B1 to hepatic macromolecules.
    Loury DN; Hsieh DP
    J Toxicol Environ Health; 1984; 13(4-6):575-87. PubMed ID: 6436500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo covalent binding of aflatoxin B1 and aflatoxin M1 to liver DNA of rat, mouse and pig.
    Lutz WK; Jaggi W; Lüthy J; Sagelsdorff P; Schlatter C
    Chem Biol Interact; 1980 Nov; 32(3):249-56. PubMed ID: 6775824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B1 by the metabolism of aflatoxin B1 by liver microsomes isolated from certain avian and mammalian species and the possible role of this metabolite in the acute toxicity of aflatoxin B1.
    Neal GE; Judah DJ; Stirpe F; Patterson DS
    Toxicol Appl Pharmacol; 1981 May; 58(3):431-7. PubMed ID: 6787737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.